ebooks logo journals logo reference works logo abstract databases logo
bullet  SIGN IN Register | Why Register? | Got a Voucher? alerts   marked lists   shopping cart 
Advert: Informa Healthcare - http://www.informahealthcare.com

informaworld

HOME   |   SEARCH   |   BROWSE
    Issues List       Latest Issue       Forthcoming Articles       Volume 50 Issue 2       Aims & Scope       Editorial Board       Instructions for Authors       Subscribe      
<< earliestearliest   < prevprev   Issue listissues   next >next   latest >>latest
Publisher Logo Publication Cover
Search within this journal

Leukemia and Lymphoma, Volume 50 Issue 2 2009

Leukemia and Lymphoma is moving!
2008 Impact Factor: 1.939 (© Thomson Reuters, Journal Citation Reports®, 2009)
ISSN: 1029-2403 (electronic) 1042-8194 (paper)
Publication Frequency: 12 issues per year
Viewing the Journal: Select the initial letter of your research topic from the list below, or enter your search term on the left.
Sort by: Title | Page | Author
< Previous • 1 • 2Next >
select-down Click for help
Commentaries
Seeking wisdom from the Seer
Peter McLaughlin; Jonathan W. Friedberg
Pages 145 – 147
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
 buy now buy now
Extranodal involvement of the head and neck region in adult T-cell leukemia/lymphoma: rare, but relevant
Eugenia Haralambieva; Andreas Rosenwald
Pages 148 – 149
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
 buy now buy now
T-cell lymphoma in the head and neck? Think about adult T-cell leukemia/lymphoma
Eric D. Hsi
Pages 150 – 151
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
 buy now buy now
Cancer care—The relation between resources and outcome
James O. Armitage
Pages 152 – 153
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
 buy now buy now
JAK2V617F: more than a clonal marker?
Ayalew Tefferi
Pages 154 – 155
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
 buy now buy now
Will changing the face of WT1 make it more attractive to T cells?
Justin Kline
Pages 156 – 157
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
 buy now buy now
Dialing resistance up a Notch
Deepa Sampath; Varsha Gandhi
Pages 158 – 159
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
 buy now buy now
Reviews
MicroRNAs in the ontogeny of leukemias and lymphomas
Muller Fabbri;  Carlo M. Croce; George A. Calin
Pages 160 – 170
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
 buy now buy now
Treatment of elderly patients with chronic lymphocytic leukemia
Barbara Eichhorst;  Valentin Goede; Michael Hallek
Pages 171 – 178
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
 buy now buy now
Original Articles: Clinical
Long-term survival of patients diagnosed with non-Hodgkin lymphoma after a previous malignancy
Dianne Pulte;  Adam Gondos; Hermann Brenner
Pages 179 – 186
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
 buy now buy now
Extranodal adult T-cell leukemia/lymphoma of the head and neck: a clinicopathological study of nine cases and a review of the literature
Takashi Miyagi;  Akitoshi Nagasaki;  Tamiko Taira;  Akihiko Shinhama;  Mikio Suzuki;  Koichi Ohshima; Nobuyuki Takasu
Pages 187 – 195
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
 buy now buy now
How much does it cost to treat children with Hodgkin lymphoma in Africa?
Daniela Cristina Stefan; David Stones
Pages 196 – 199
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
 buy now buy now
Metallothionein as a useful marker in Hodgkin lymphoma subclassification
Milena Penkowa;  Brit Ladegaard Sørensen;  Signe Lidou Nielsen; Per Boye Hansen
Pages 200 – 210
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
 buy now buy now
Toxicity of fludarabine and cyclophosphamide with or without rituximab as initial therapy for patients with previously untreated mantle cell lymphoma: results of a randomised phase II study
Heather E. Eve;  David Linch;  Wendi Qian;  Moira Ross;  John F. Seymour;  Paul Smith;  Lindsey Stevens; Simon A. J. Rule
Pages 211 – 215
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
 buy now buy now
Single daily dose of intravenous busulfan and melphalan as a conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation: a phase II trial
Margarita Blanes;  Javier de la Rubia;  Juan J. Lahuerta;  José D. González;  Paz Ribas;  Carlos Solano;  Adrián Alegre; Miguel A. Sanz
Pages 216 – 222
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
 buy now buy now
Predicting durable remissions following thalidomide therapy for relapsed myeloma
Hang Quach;  Linda Mileshkin;  John F. Seymour;  Alvin Milner;  David Ritchie;  Simon Harrison;  David Westerman; H. Miles Prince
Pages 223 – 229
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
 buy now buy now
The impact of extramedullary disease at presentation on the outcome of myeloma
Ping Wu;  Faith E. Davies;  Kevin Boyd;  Karen Thomas;  Sharon Dines;  Radovan M. Saso;  Mike N. Potter;  Mark E. Ethell;  Bronwen E. Shaw; Gareth J. Morgan
Pages 230 – 235
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
 buy now buy now
Regulation of the CD56 promoter and its association with proliferation, anti-apoptosis and clinical factors in multiple myeloma
Tina Damgaard;  Lene M. Knudsen;  Inger Marie S. Dahl;  Peter Gimsing;  Marianne Lodahl; Thomas Rasmussen
Pages 236 – 246
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
 buy now buy now
JAK2V617F mutation in essential thrombocythemia: correlation with clinical characteristics, response to therapy and long-term outcome in a cohort of 275 patients
Francesca Palandri;  Emanuela Ottaviani;  Federica Salmi;  Lucia Catani;  Nicola Polverelli;  Mauro Fiacchini;  Giovanni Martinelli;  Michele Baccarani; Nicola Vianelli
Pages 247 – 253
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles
 buy now buy now
select-up

Privacy Policy | Terms & Conditions | Accessibility | RSS
FAQs in: English . Français . Español . 中文(简体和繁體)
© 2009 Informa plc